Navigation Links
FDA Approves Rituxan to Treat Chronic Lymphocytic Leukemia
Date:2/18/2010

drug, they release toxins into the bloodstream that can cause acute kidney injury and increase the levels of potassium and phosphate in the blood.

Rituxan is manufactured by San Francisco based-Genentech, a member of the Roche Group.

Media Inquiries: Karen Riley, 301-796-4674; karen.riley@fda.hhs.gov

mailto:Consumer Inquiries: 888-INFO-FDA

SOURCE U.S. Food and Drug Administration

Back to top

RELATED LINKS
http://www.fda.gov/

'/>"/>

SOURCE U.S. Food and Drug Administration
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. FDA Approves Lillys Osteoporosis Drug EVISTA(R) (raloxifene HCl) to Reduce The Risk of Invasive Breast Cancer in Two Populations of Postmenopausal Women
2. Health Canada Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/ tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for HIV
3. FDA Approves Cymbalta(R) for Maintenance Treatment of Major Depressive Disorder
4. European Commission Approves ATRIPLA(R) (efavirenz 600 mg/emtricitabine 200 mg/tenofovir disoproxil fumarate 300 mg), the First Once-Daily Single Tablet Regimen for Virologically Suppressed Adults With HIV-1 Infection
5. FDA Approves MiddleBrooks Amoxicillin PULSYS for Pharyngitis/Tonsillitis in Adolescents and Adults
6. FDA Approves XYZAL(R) (levocetirizine dihydrochloride) Oral Solution for the Relief of Seasonal and Year Round Allergies and Chronic Idiopathic Urticaria
7. UM Maryland Industrial Partnerships Program Approves 18 Collaborative Research Projects, Worth $4.4 Million, Between University Faculty, State Technology Companies
8. U.S. Food and Drug Administration Approves ABILIFY(R) (aripiprazole) for the Acute Treatment of Manic and Mixed Episodes Associated With Bipolar I Disorder in Pediatric Patients (10 to 17 Years of Age)
9. U.S. Food and Drug Administration Approves ORENCIA(R) (abatacept) for the Treatment of Moderate-to-Severe Polyarticular Juvenile Idiopathic Arthritis (JIA) in Patients Six Years and Older
10. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
11. EPA Approves XDS-CALUX(R) as Alternate Dioxin Test Method 4435
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... YORK , July 31, 2014 ... discovering and developing better, faster and affordable treatments, ... as Senior Vice President, External Affairs. Mr. Brock ... as Head of Major Donor Relations for WWF ... In his role, Mr. Brock will guide the ...
(Date:7/31/2014)... SPRINGFIELD, Ill. , July 31, 2014 /PRNewswire/ ... (LRS) announced a new extension to its PageCenterX ... software is designed to provide downtime ... unplanned system outages. LRS is releasing the product ... the healthcare environment, EMR applications experience outages for ...
(Date:7/31/2014)... Deutschland, 31. Juli 2014  invendo medical ... („robotischen") Koloskopie-Systems für den Einmalgebrauch, verkündete heute, ... weltweit anerkannter Manager im Bereich Medizintechnik, als ... stößt. Logo - ... hochangesehener globaler Visionär der Medizintechnikbranche. Er war ...
Breaking Medicine Technology:TB Alliance Appoints Willo Brock Senior Vice President, External Affairs 2LRS Announces Downtime Reporting Solution for Healthcare 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 2invendo medical holt Nachum (Homi) Shamir in den Board of Directors des Unternehmens 3
... Palatin Technologies,Inc. (AMEX: PTN ) announced today ... trial of PL-3994, a long acting analog of ... decompensated congestive,heart failure (CHF). The trial is being ... to the U.S. Food and Drug,Administration. Future plans ...
... Third Quarter 2007 Earnings release, you are,invited to listen to ... on Tuesday, November 6, 2007 at 9:30 a.m. EST, with ... Chief,Financial Officer. What: QIAGEN N.V. ... Tuesday, November 6, 2007 at 9:30 a.m. EST, ...
Cached Medicine Technology:Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure 2Palatin Technologies, Inc. Reports Initiation of Human Trials for the Treatment of Congestive Heart Failure 3QIAGEN N.V. (Nasdaq: QGEN) Invites You to Join Its Third Quarter 2007 Earnings Conference Call on the Web 2
(Date:7/31/2014)... The VitalSleep anti snoring device is a mandibular advancement splint ... snorers airway to quiet snoring. , Dawn M. of Utah ... her husband by allowing them to share the same bedroom again. ... about 15 years ago and I remember nights when it was ... had to head downstairs for any relief. As the years have ...
(Date:7/31/2014)... York, New York (PRWEB) July 31, 2014 ... against Ethicon, Inc. continue to move forward in the ... District of West Virginia, Bernstein Liebhard LLP reports. According ... been scheduled to consider certain defense motions now pending ... before the U.S. Magistrate Judge on Tuesday, August 5th ...
(Date:7/31/2014)... of heroin use has been rising steadily in the ... on Drug Use and Health, the number of individuals ... (373,000) and 2012 (669,000). Emerging evidence suggests the increase ... transition from oral and/or intranasal PO use to heroin ... use, and ultimately, heroin injection. This drug-use trajectory ...
(Date:7/31/2014)... Live To Be Sober , a no-cost 24/7 confidential ... program information to people who want to help a ... addiction, proudly announced today that it has entered into ... boy, gone good. , "NBC's The Voice touched on ... new single Stomp (#Stomp; available on iTunes ) ...
(Date:7/31/2014)... Ticket Down is a reliable source ... Goods Park in suburban Denver on Tuesday, September 9th. ... has found a second home competing on American soil. They ... international friendly games and will look to have another successful ... in Commerce City, Colorado. The match will be Mexico’s second ...
Breaking Medicine News(10 mins):Health News:New Snoring Mouthpiece Reviews from VitalSleep 2Health News:Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports 2Health News:Ethicon Transvaginal Mesh Lawsuits Move Forward, With Scheduling of Hearing in Federal Litigation, Bernstein Liebhard LLP Reports 3Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 2Health News:NYU CDUHR researchers look at prescription opioid abuse among young adults in NYC 3Health News:Addiction Referral Service Live To Be Sober (LiveToBeSober.com) Announces Sponsorship of Jared Blake: Country Music’s Bad Boy, Gone Good 2Health News:Addiction Referral Service Live To Be Sober (LiveToBeSober.com) Announces Sponsorship of Jared Blake: Country Music’s Bad Boy, Gone Good 3Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 2Health News:Mexico vs. Bolivia Tickets at Dick’s Sporting Goods Park in Commerce City (Denver), CO Now Available at Ticket Down 3
... abstracts underscoring the importance of testing for BRCA1/2 mutations ... week,s Society of Gynecologic Oncologists 39th Annual Meeting on ... M. D. Anderson Cancer Center. , In ... M.D. Anderson found advanced- stage ovarian cancer patients with ...
... 10 Give an Hour, (http://www.giveanhour.org ), a ... returning Veterans and their loved ones,announces that there ... In an effort to supplement the mental ... military health care system, Give an Hour,s,services are ...
... Medco Health,Solutions, Inc. (NYSE: MHS ) is scheduled ... On Monday, March 17, 2008, Timothy C. Wentworth, president ... specialty pharmacy,subsidiary, is scheduled to address the 28th Annual ... Boston Marriott Copley,Place will begin at 1:45 p.m. ET., ...
... for environmental, biological diseases if same physician is used ... for by the same doctor during their first six months ... doctors to receive proper screening for lead poisoning, anemia and ... study looked at 1,564 infants covered by Medicare. All the ...
... CITY, March 10 ZARS Pharma, Inc. ... Galderma Pharma S.A. the,exclusive promotion and distribution ... and Canada for Pliaglis(TM) (lidocaine and tetracaine) ... and safe local,anesthesia in patients undergoing potentially ...
... in California participated, MANHATTAN BEACH, Calif., March 10 ... by 2011 and the majority of,California,s population by 2040. ... the highest rate among all ethnic groups., "In ... discussing,with regard to the Latino community is immigration, there ...
Cached Medicine News:Health News:Advanced-stage ovarian cancer patients with BRCA live longer, may respond better to treatment 2Health News:1,000 Mental Health Professionals Join National Network to Provide Free Counseling to Returning Veterans and their Families 2Health News:Medco to Present at Cowen and Company and Lehman Brothers Health Care Conferences 2Health News:Continuous Doctor Care Key to Childhood Screenings 2Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 2Health News:ZARS Pharma Announces Worldwide License Agreement With Galderma Pharma S.A. for Pliaglis(TM), a Topical Local Anesthetic 3Health News:New Survey Shows Solutions to Improve Latinos' Access to Health Care in California 2
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: